Evidence map

ArticleDiabetes, obesity & metabolism2021

Response to Dahl et al.: Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes.

Michael Horowitz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34169640